Ro and Peter MD overlap on weight loss, testosterone replacement therapy, and hair loss, but Ro ships real Wegovy with insurance navigation built in while Peter MD leans on compounded semaglutide and a price match guarantee with 20% discount. Ro covers all 50 states plus DC; Peter MD reaches 39 states.
Pick Ro if
If you want Wegovy by name and someone to sort your insurance, Ro fits: you get coaching, tracking, and 1-on-1 check-ins from $45 your first month.
Pick Peter MD if
You're after transparent pricing, a price match guarantee, and the flexibility to bundle TRT with NAD+ or Sermorelin without surprise bills.
Choose Ro if you're in any US state or DC and want a single platform covering Wegovy, at-home labs, and hair loss tracking with over 1 million prescriptions behind it. Choose Peter MD if you want compounded semaglutide, a one-time $70 provider fee for hair loss, and a price match that cuts costs by 20%. Ro holds a 8.9 rating across 32,100 reviews versus Peter MD's 8.4 across 22,400. Depends what you care about.
Quick Answer
Best overallPeter MD
Most reviewedPeter MD
Peter MD is our overall pick for weight loss, based on ratings, reviews, and feature coverage.
Provider Overview
8.8(3,200 reviews on Trustpilot)
Ro (formerly Roman) is a full-service telehealth platform offering treatments for ED, hair loss, weight loss, and more. Known for its strong weight loss program with personalized coaching.
Adults with a BMI over 27 who want real Wegovy, not a compounded version.
You prefer having insurance paperwork handled without doing it yourself.
You want coaching and check-ins included, not just a prescription and a portal.
Not for
Not for you if you are pregnant or actively trying to become pregnant.
Not the right fit if your BMI is under 27 and you lack a weight-related condition.
Not for you if you have a history of an eating disorder like anorexia or bulimia.
Peter MD
This is for
Adults with a BMI over 27 who want compounded semaglutide at a transparent price.
You prefer working directly with a board-certified obesity medicine specialist, not a general practitioner.
You want all supplies and shipping included, with no surprise charges at checkout.
Not for
Not for you if you are pregnant, planning pregnancy, or currently breastfeeding.
Not a fit if your BMI is under 27 with no weight-related health conditions.
Not for you if you need in-person care or bariatric surgery evaluation.
About This Comparison
Our Editorial Standards
This ro vs peter md provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, service areas, and verified customer reviews.
Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers
Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.
Independent ResearchUnbiased provider comparisons
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated March 18, 2026
Licensed Providers OnlyAll listed services are US-licensed
Ro vs Peter MD: Complete Comparison Guide
Written by Eric GoldEditor-in-Chief
13 min readUpdated March 18, 2026
complete analysis comparing Ro and Peter MD across pricing, features, treatments, and user experience.
Platform Overview
Peter MD operates as premium men's health specialist serving exclusively male patients for erectile dysfunction, hair loss, and testosterone optimization. The platform charges $99-149 monthly for hair loss treatment ($1,188-1,788 annually) including finasteride and minoxidil prescriptions through synchronous video consultations with board-certified physicians. Peter MD emphasizes specialized men's health expertise, complete medical evaluation, and multi-condition coordination across ED, hormone management, and androgenetic alopecia within unified men's health platform. The premium positioning targets affluent men prioritizing specialized care over cost considerations, operating primarily self-pay model with limited insurance acceptance. Source: Peter MD platform analysis 2025
Ro operates multi-category men's and women's health telemedicine platform offering hair loss, weight loss, erectile dysfunction, sexual wellness, and skincare services. The platform prescribes FDA-approved pharmaceutical treatments including finasteride, minoxidil, and spironolactone through asynchronous consultations with physicians and nurse practitioners at $20-90 monthly ($240-1,080 annually) depending on medication selection. Ro positions as complete digital health service with competitive pharmaceutical pricing, evidence-based treatment approaches, and efficient asynchronous consultation model. The multi-category platform serves both men and women across diverse health concerns, emphasizing convenience, affordability, and nationwide provider network accessibility. Source: Ro platform analysis 2025
This comparison examines premium specialized men's health service (Peter MD) versus affordable multi-category telemedicine platform (Ro) for hair loss treatment. The platforms differ dramatically in pricing tiers (premium vs budget-to-mid-market), consultation models (synchronous video vs asynchronous messaging), provider types (physician-only vs physician/NP), service scope (men's health specialist vs complete multi-category), target demographics (men only vs both genders), and positioning (luxury expertise vs accessible convenience). Selection depends on budget considerations, gender, value placed on specialized men's health coordination, consultation format preferences, and acceptance of premium pricing for specialized expertise versus choosing affordable pharmaceutical access.
Pricing Differential and Value Proposition Analysis
Peter MD charges premium pricing at $99-149 monthly ($1,188-1,788 annually) for hair loss treatment, positioning as specialized men's health service substantially more expensive than mass-market telemedicine. The pricing reflects physician-only consultations, synchronous video appointments, specialized men's health expertise, and premium service positioning. Consultation fees remain predominantly self-pay with limited insurance acceptance, making full retail pricing typical for most patients. Annual costs reach $1,188-1,788 for hair loss treatment alone, targeting affluent demographic prioritizing specialized expertise over cost optimization. The premium model suits patients valuing men's health coordination depth and physician consultation time without budget constraints. Source: Peter MD pricing structure 2025
Ro operates budget-to-mid-market pricing model charging $20-90 monthly ($240-1,080 annually) for hair loss prescriptions depending on medication selection—minoxidil alone $20-30 monthly, finasteride alone $35-50 monthly, combination therapy $60-90 monthly. The competitive pricing reflects asynchronous consultation efficiency, multi-category platform economics, and volume-oriented business model prioritizing accessibility over premium positioning. Annual costs range $240-1,080 with transparent subscription tiers and no hidden fees, making Ro substantially more affordable than specialized premium services. The platform accepts some insurance for prescription medications potentially reducing costs further, though operates primarily self-pay with predictable pricing regardless of insurance status. Source: Ro pricing structure 2025
The pricing differential is dramatic: Ro costs $240-1,080 annually versus Peter MD's $1,188-1,788, representing 80-90% cost savings for single medications or 40-60% savings for combination therapy through Ro's budget-oriented model. Over typical 5-year hair loss treatment commitment, cost difference reaches $4,740-7,740 favoring Ro's affordable approach. Peter MD's premium charges 2-7x more than Ro depending on medication selection, justified by specialized men's health expertise, synchronous physician video consultations, and multi-condition coordination capabilities. Value proposition depends critically on whether specialized coordination and video consultation format warrant $900-1,500+ annual premium for patients with straightforward male pattern baldness versus complex men's health coordination needs. Source: Telemedicine pricing comparison
Consultation Models: Synchronous Video vs Asynchronous Efficiency
Peter MD requires synchronous video consultations with board-certified physicians for hair loss evaluation and prescription. Patients schedule appointments (typically 15-30 minutes) where providers conduct real-time clinical interviews, visual assessments, and complete medical discussions before prescribing treatments. The synchronous format enables bidirectional conversation, clarification questions, and thorough medical evaluation beyond photograph review. Physicians assess patient concerns holistically, coordinate hair loss treatment with erectile dysfunction or testosterone management when appropriate, and provide personalized recommendations during face-to-face virtual interaction. This consultation depth requires appointment scheduling and dedicated visit time but enables complete men's health evaluation integrating multiple clinical considerations. Source: Synchronous telemedicine models
Ro employs asynchronous consultation model where patients complete questionnaires, upload photographs, and submit treatment requests without scheduled appointments. Physicians and nurse practitioners review submitted information within 24-48 hours, prescribing medications if clinically appropriate or requesting additional information if needed. The asynchronous approach eliminates appointment scheduling, wait times, and real-time conversation requirements—patients receive prescriptions via platform messaging without video interaction. This model prioritizes convenience and cost efficiency for straightforward androgenetic alopecia cases where photograph-based assessment and medical history screening sufficiently determine treatment appropriateness. Quarterly touchpoints occur through messaging rather than scheduled video appointments. Source: Asynchronous telemedicine effectiveness
The consultation format distinction significantly impacts convenience, cost, and clinical depth trade-offs. Peter MD's synchronous video model provides complete evaluation, real-time discussion, and diagnostic conversation depth but requires appointment scheduling, dedicated time commitment, and premium pricing reflecting physician consultation costs. Ro's asynchronous model maximizes convenience—patients submit information anytime without appointments—and enables budget pricing through consultation efficiency, but limits provider interaction to one-way review rather than bidirectional conversation. Patients with straightforward male pattern baldness seeking convenient prescription access often find Ro's asynchronous model sufficient; those desiring thorough medical evaluation or multi-condition coordination benefit from Peter MD's synchronous consultation depth despite appointment requirements and premium costs. Source: Consultation format comparison
Specialized Men's Health vs Multi-Category Platform Breadth
Peter MD focuses exclusively on men's health categories—hair loss, erectile dysfunction, and testosterone optimization—enabling specialized coordination across male-specific conditions. Physicians assess interactions between treatments: evaluating whether finasteride for hair loss affects ED therapy effectiveness, optimizing testosterone levels for both sexual function and hair health, coordinating multiple men's health interventions through integrated consultation. This concentrated scope creates expertise in men's health coordination and multi-condition integration unavailable through generalist platforms. However, the narrow focus limits utility for patients with health needs beyond men's health domains or those seeking only hair loss treatment without ED or testosterone concerns requiring coordination. Source: Specialized men's health telemedicine
Ro operates multi-category platform where hair loss treatment exists alongside weight loss, erectile dysfunction, sexual wellness, and skincare services. This breadth enables patients to manage multiple health needs through unified account—men accessing both hair loss and ED treatment, patients coordinating multiple conditions across platform categories. However, the multi-category breadth means clinical protocols must accommodate diverse conditions, potentially diluting hair loss specialization compared to single-focus or men's health specialist services. The complete model suits patients managing diverse health needs through consolidated telemedicine platform versus those seeking only hair loss treatment without broader healthcare coordination requirements. Gender-inclusive design serves both men and women across service categories. Source: Multi-category telehealth platforms
The platform breadth distinction affects value for different patient profiles: Peter MD's men's health focus suits males managing multiple conditions specifically within men's health categories (hair loss, ED, testosterone) benefiting from specialized coordination, while Ro's multi-category model suits patients with diverse health needs across multiple categories or those seeking only hair loss treatment at budget pricing without specialized men's health coordination. Neither model proves universally superior—value depends on individual health management requirements beyond isolated hair loss treatment. Patients seeking only hair loss prescriptions without multi-condition needs find Ro's budget pricing compelling; those requiring men's health coordination across ED, hormones, and hair loss may value Peter MD's specialized integration despite premium costs. Source: Healthcare specialization vs completeness
Provider Credentials and Clinical Expertise Concentration
Peter MD exclusively employs board-certified physicians (no nurse practitioners) for all consultations, emphasizing physician-led care as premium service differentiator. The physicians practice men's health specifically—erectile dysfunction, testosterone optimization, and male pattern baldness—developing concentrated expertise through repeated exposure to male-specific conditions within limited therapeutic scope. This specialization creates depth in men's health presentations and multi-condition coordination beyond general telemedicine providers. However, individual physician hair loss case volume may not dramatically exceed platforms focused more broadly, making specialized expertise relative rather than absolute. The physician-only model supports premium pricing justification and specialized positioning. Source: Physician specialization in telemedicine
Ro employs both physicians and nurse practitioners for hair loss consultations, with credential mix varying by state regulatory requirements and patient case complexity. Nurse practitioners provide appropriate clinical oversight for routine hair loss prescriptions, operating within scope of practice for standard androgenetic alopecia treatment. Physicians handle complex cases requiring broader diagnostic consideration or specialty consultation. The provider mix enables cost-efficient consultation model while maintaining clinical appropriateness—NPs manage straightforward cases while physicians address complex presentations. Ro providers practice across multiple health categories (hair loss, weight loss, ED, sexual wellness) rather than specializing exclusively in men's health, bringing generalist medical knowledge rather than concentrated men's health expertise. Source: Nurse practitioner scope in telemedicine
The provider credential distinction reflects service positioning: Peter MD's physician-only men's health specialists provide concentrated expertise in male-specific conditions and multi-condition coordination, while Ro's physician/NP mix enables cost-efficient consultations appropriate for routine hair loss prescriptions without premium specialized positioning. For straightforward male pattern baldness, clinical outcomes likely differ minimally between competent NPs and physicians or generalists and specialists—both credential types appropriately prescribe finasteride and minoxidil. For complex presentations requiring men's health coordination or diagnostic depth, Peter MD's specialized physician model may provide advantages. The credential difference matters most for patients valuing physician-only care or requiring integrated men's health management beyond isolated hair loss treatment. Source: Provider credentials and outcomes
Gender Access and Target Market Demographics
Peter MD serves exclusively male patients, with entire platform designed around men's health concerns including hair loss, erectile dysfunction, and testosterone optimization. Women cannot access Peter MD regardless of clinical appropriateness or willingness to pay premium pricing—the male-only limitation stems from specialized focus on men's conditions and masculine brand positioning. This demographic restriction eliminates half the hair loss patient population from consideration, though men receive platform entirely dedicated to male health optimization without content directed toward other demographics. The specialization creates cohesive men's health identity targeting affluent male demographic seeking specialized expertise. Source: Gender-specific health platforms
Ro serves both men and women with gender-appropriate pharmaceutical interventions: finasteride for men, spironolactone and minoxidil for women, with clinical protocols adapted to gender-specific considerations including pregnancy contraindication management and hormonal factor assessment. The gender-inclusive model accommodates entire market without demographic restrictions, maximizing addressable patient population and household utility—couples or families managing multiple health needs through unified platform. Multi-category breadth particularly benefits women coordinating hormonal treatments, sexual wellness, and hair loss management through consolidated care, while men access ED treatment alongside hair loss prescriptions. The inclusive approach prioritizes market accessibility over specialized demographic targeting. Source: Gender-inclusive telemedicine
Gender inclusivity represents mandatory selection factor: women seeking hair loss treatment must choose Ro or other gender-inclusive platforms given Peter MD's male-only model. Men have access to both options, making gender factor relevant primarily for households where multiple family members benefit from unified platform (favoring Ro) versus individual men seeking specialized men's health expertise (potentially justifying Peter MD despite premium). The demographic restriction at Peter MD limits market consideration to male patients exclusively, while Ro's inclusive model maintains accessibility across gender demographics with broader household utility. Source: Demographics in healthcare platforms
How We Tested Ro vs Peter MD
Methodology & Clinical Evidence
This comparison synthesizes publicly available information about Peter MD and Ro service models, consultation formats, pricing structures, provider credentials, and clinical scope as of January 2026. Analysis incorporates platform marketing materials, terms of service, provider credential disclosures, pricing schedules, and service positioning statements from official websites. Clinical effectiveness assessments reference FDA approval data for finasteride and minoxidil in androgenetic alopecia treatment, with efficacy expectations identical across platforms given both prescribe same pharmaceutical interventions. Consultation model comparisons incorporate telemedicine literature evaluating synchronous versus asynchronous care formats, provider credential research, and cost-effectiveness studies. Pricing analyses reflect advertised subscription rates without accounting for promotional discounts or individual insurance variables (limited impact given predominantly self-pay models). Gender-specific considerations incorporate urology and men's health literature. Platform scope distinctions represent observable differences in service categories, specialization focus, and target demographics. This analysis does not constitute medical advice; patients should consult licensed healthcare providers to determine appropriate hair loss treatment based on individual medical history, underlying conditions, and diagnostic evaluation requirements.
Final Verdict: Ro vs Peter MD
Final Verdict: Budget-Efficient Pharmaceutical Access vs Premium Men's Health Specialization
Peter MD and Ro represent dramatically different market positions—premium specialized men's health service versus budget-efficient multi-category pharmaceutical platform. Comparison reveals Ro providing superior value for most patients through dramatically lower costs with appropriate medical oversight, while Peter MD targets niche affluent demographic valuing specialized men's health coordination despite substantial premium.
Ro excels across multiple dimensions for straightforward hair loss treatment: costs $240-1,080 annually (80-90% less for single medications, 40-60% less for combinations), prescribes identical FDA-approved medications with appropriate medical supervision, offers asynchronous consultation convenience without appointment requirements, serves both men and women through gender-inclusive platform, and provides multi-category breadth for patients managing diverse health needs. The value proposition strongly favors Ro—patients pay dramatically less for evidence-based pharmaceutical treatment with appropriate oversight, saving $4,740-7,740 over typical 5-year treatment commitment.
Peter MD appeals to specific affluent male demographic valuing specialized men's health expertise, synchronous physician video consultations, and integrated coordination across hair loss, erectile dysfunction, and testosterone optimization. Premium pricing ($1,188-1,788 annually) purchases specialized consultation depth and men's health coordination capabilities rather than superior medication efficacy. The platform suits men managing multiple men's health conditions benefiting from integrated approach or those prioritizing specialized expertise over cost considerations.
The fundamental analysis reveals asymmetric comparison: Ro provides dramatically better value (2-7x lower cost for identical medications), while Peter MD serves premium positioning targeting affluent patients willing to pay $900-1,500+ annual premium for specialized men's health coordination. Gender access, budget considerations, and multi-condition coordination needs represent critical selection factors.
Choose Ro if:
You prioritize cost-effectiveness (saves $4,740-7,740 over 5 years vs Peter MD)
You have straightforward male pattern baldness without complex men's health coordination needs
You value asynchronous consultation convenience without appointment scheduling
You are female seeking hair loss treatment (Peter MD serves men only—mandatory factor)
You want multi-category platform managing diverse health needs through unified account
You seek budget-efficient access to FDA-approved medications with appropriate oversight
You accept physician/NP consultations providing adequate care for routine prescriptions
Choose Peter MD if:
You have financial capacity for premium pricing ($1,188-1,788/year without budget constraints)
You manage multiple men's health conditions (hair loss, ED, testosterone) benefiting from integrated coordination
You value synchronous video consultations with specialized men's health physicians
You prioritize men's health expertise and coordination depth over cost considerations
You want physician-only care rather than physician/NP consultation model
You accept $900-1,500+ annual premium for specialized services versus efficient pharmaceutical access
You seek premium positioning and specialized men's health focus regardless of cost differential
Bottom line: Ro and Peter MD target fundamentally different market segments—budget-efficient pharmaceutical access versus premium men's health specialization. Objective analysis reveals Ro providing superior value for most patients through dramatically lower costs (2-7x less) with appropriate medical oversight for identical FDA-approved medications. Peter MD targets affluent niche demographic willing to pay substantial premium for specialized men's health coordination—justified for complex multi-condition scenarios (hair loss plus ED, testosterone) but representing significant over-payment for straightforward androgenetic alopecia. Women must choose Ro or alternatives given Peter MD's male-only service. Men with straightforward hair loss and budget awareness overwhelmingly benefit from Ro's efficient affordable model; only affluent patients managing complex men's health coordination needs or specifically valuing premium specialized expertise find Peter MD's substantial cost premium justified.
Sources & References
Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.
Peter MDTelehealth platform for men's health treatments
RoComprehensive telehealth platform for men's and women's health
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
Eric Gold is a writer and editor with a background in digital media and consumer research. He has spent the last several years covering the health and wellness industry, with a particular focus on telehealth services and direct-to-consumer healthcare. Eric believes that access to clear, unbiased information should not require a medical degree. When he is not reviewing telehealth platforms, he enjoys hiking, cooking, and following the stock market a little too closely.
Medical Disclaimer: The information on this page is for educational purposes only and is not medical advice. Always consult with a licensed healthcare provider before starting any treatment. Read our full medical disclaimer.
